Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Weigel

Showing results (401-410 of 423) with videos related to

Pageof 43
Sort By:
Cancer Research|June 10, 2026
GNAQ Induces Melanomagenesis in Mitfa-Independent Melanocyte Progenitors in a Zebrafish Model of Uveal MelanomaJulius I Yevdash, Delaney Robinson, Rachel Moore, et al.
JCO Precision Oncology|September 19, 2024
Palbociclib in Solid Tumor Patients With Genomic Alterations in the cyclinD-cdk4/6-INK4a-Rb Pathway: Results From National Cancer Institute-Children's Oncology Group Pediatric Molecular Analysis for Therapy Choice Trial Arm I (APEC1621I)Margaret E Macy, Rajen Mody, Joel M Reid, et al.
Annals of Surgical Oncology|January 26, 2025
ASO Visual Abstract: Quality of Cancer Recurrence Data in the National Cancer Database: A Reappraisal of Reporting ReadinessKelley Chan, Bryan E Palis, Joseph H Cotler, et al.
Annals of Surgical Oncology|December 31, 2024
Quality of Cancer Recurrence Data in the National Cancer Database: A Reappraisal of Reporting ReadinessKelley Chan, Bryan E Palis, Joseph H Cotler, et al.
Pediatric Blood & Cancer|May 2, 2025
A Phase 1/2 Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric and Young Adult Solid TumorsFilemon S Dela Cruz, Elizabeth Fox, Steven G DuBois, et al.
JCO Precision Oncology|June 27, 2024
Phase II Study of Ulixertinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Alterations: APEC1621J of the National Cancer Institute-Children's Oncology Group Pediatric MATCH TrialKieuhoa T Vo, Amit J Sabnis, P Mickey Williams, et al.
Iscience|December 26, 2023
Sex differences in left-ventricular strain in a murine model of coxsackievirus B3 myocarditisDamian N Di Florio, Logan P Macomb, Presley G Giresi, et al.
JCO Precision Oncology|September 19, 2024
Phase II Study of Samotolisib in Children and Young Adults With Tumors Harboring Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Pathway Alterations: Pediatric MATCH APEC1621DTheodore W Laetsch, Kathleen Ludwig, P Mickey Williams, et al.
The Oncologist|May 30, 2024
Olaparib for childhood tumors harboring defects in DNA damage repair genes: arm H of the NCI-COG Pediatric MATCH trialJulia L Glade Bender, Kerice Pinkney, Paul M Williams, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 7, 2021
Development of an exosomal gene signature to detect residual disease in dogs with osteosarcoma using a novel xenograft platform and machine learningKelly M Makielski, Alicia J Donnelly, Ali Khammanivong, et al.
Pageof 43

Showing results (401-410 of 423) with videos related to

Sort By:
Pageof 43
Cancer Research|June 10, 2026
GNAQ Induces Melanomagenesis in Mitfa-Independent Melanocyte Progenitors in a Zebrafish Model of Uveal MelanomaJulius I Yevdash, Delaney Robinson, Rachel Moore, et al.
JCO Precision Oncology|September 19, 2024
Palbociclib in Solid Tumor Patients With Genomic Alterations in the cyclinD-cdk4/6-INK4a-Rb Pathway: Results From National Cancer Institute-Children's Oncology Group Pediatric Molecular Analysis for Therapy Choice Trial Arm I (APEC1621I)Margaret E Macy, Rajen Mody, Joel M Reid, et al.
Annals of Surgical Oncology|January 26, 2025
ASO Visual Abstract: Quality of Cancer Recurrence Data in the National Cancer Database: A Reappraisal of Reporting ReadinessKelley Chan, Bryan E Palis, Joseph H Cotler, et al.
Annals of Surgical Oncology|December 31, 2024
Quality of Cancer Recurrence Data in the National Cancer Database: A Reappraisal of Reporting ReadinessKelley Chan, Bryan E Palis, Joseph H Cotler, et al.
Pediatric Blood & Cancer|May 2, 2025
A Phase 1/2 Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric and Young Adult Solid TumorsFilemon S Dela Cruz, Elizabeth Fox, Steven G DuBois, et al.
JCO Precision Oncology|June 27, 2024
Phase II Study of Ulixertinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Alterations: APEC1621J of the National Cancer Institute-Children's Oncology Group Pediatric MATCH TrialKieuhoa T Vo, Amit J Sabnis, P Mickey Williams, et al.
Iscience|December 26, 2023
Sex differences in left-ventricular strain in a murine model of coxsackievirus B3 myocarditisDamian N Di Florio, Logan P Macomb, Presley G Giresi, et al.
JCO Precision Oncology|September 19, 2024
Phase II Study of Samotolisib in Children and Young Adults With Tumors Harboring Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Pathway Alterations: Pediatric MATCH APEC1621DTheodore W Laetsch, Kathleen Ludwig, P Mickey Williams, et al.
The Oncologist|May 30, 2024
Olaparib for childhood tumors harboring defects in DNA damage repair genes: arm H of the NCI-COG Pediatric MATCH trialJulia L Glade Bender, Kerice Pinkney, Paul M Williams, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 7, 2021
Development of an exosomal gene signature to detect residual disease in dogs with osteosarcoma using a novel xenograft platform and machine learningKelly M Makielski, Alicia J Donnelly, Ali Khammanivong, et al.
Pageof 43